Research Progress of SGLT2 Inhibitors in the Treatment of Acute Heart Failure: A Narrative Review.

Int J Gen Med · 2026 · PMC13265260 · PMID 42306580

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

17 Although dapagliflozin was well tolerated, the primary composite endpoint of cardiovascular death or worsening heart failure at 2 months did not reach statistical significance. 17 This neutral primary result is important and indicates that the benefits of in-hospital dapagliflozin initiation should not be overstated.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.